Hot Features
プレミアム
Catalyst Pharmaceuticals Inc (CPRX)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-02-17 | Mr. Gregg RussoChief HR Officer | 476.00 | 0.00 | Derivative Exercise and Retained Stock | - | 476.00 | - |
| 2026-02-17 | Mr. Gregg RussoChief HR Officer | -211.00 | 0.00 | Derivative Exercise and Sale | - | 476.00 | - |
| 2026-01-05 | Mr. Richard John DalyPresident, CEO & Director | 31.53k | 0.00 | Derivative Exercise and Retained Stock | - | 271.27k | 13.15% |
| 2026-01-05 | Mr. Richard John DalyPresident, CEO & Director | -10.58k | 0.00 | Derivative Exercise and Sale | - | 271.27k | - |
| 2026-01-05 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | 5.06k | 0.00 | Derivative Exercise and Retained Stock | - | 13.67k | 58.78% |
| 2026-01-05 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | -2.08k | 0.00 | Derivative Exercise and Sale | - | 13.67k | - |
| 2025-12-29 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | 4.83k | 0.00 | Derivative Exercise and Retained Stock | - | 14.34k | 50.77% |
| 2025-12-29 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -3.84k | 0.00 | Derivative Exercise and Sale | - | 14.34k | - |
| 2025-12-29 | Mr. Richard John DalyPresident, CEO & Director | 810.00 | 0.00 | Derivative Exercise and Retained Stock | - | 239.74k | 0.34% |
| 2025-12-29 | Mr. Richard John DalyPresident, CEO & Director | -524.00 | 0.00 | Derivative Exercise and Sale | - | 239.74k | - |
| 2025-12-29 | Mr. Donald A. DenkhausIndependent Director | 1.33k | 0.00 | Derivative Exercise and Retained Stock | - | 498.77k | 0.27% |
| 2025-12-29 | Mr. Brian ElsberndCCO & Chief Legal Officer | 4.04k | 0.00 | Derivative Exercise and Retained Stock | - | 242.50k | 1.70% |
| 2025-12-29 | Mr. Brian ElsberndCCO & Chief Legal Officer | -2.62k | 0.00 | Derivative Exercise and Sale | - | 242.50k | - |
| 2025-12-29 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 14.00k | 0.00 | Derivative Exercise and Retained Stock | - | 1.09M | 1.30% |
| 2025-12-29 | Ms. Molly HarperLead Independent Director | 1.33k | 0.00 | Derivative Exercise and Retained Stock | - | 3.69k | 56.53% |
| 2025-12-29 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | 19.55k | 0.00 | Derivative Exercise and Retained Stock | - | 4.17M | 0.47% |
| 2025-12-29 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | -6.79k | 0.00 | Derivative Exercise and Sale | - | 4.17M | - |
| 2025-12-29 | Dr. Preethi SundaramChief Strategy Officer | 4.30k | 0.00 | Derivative Exercise and Retained Stock | - | 54.80k | 8.51% |
| 2025-12-29 | Dr. Preethi SundaramChief Strategy Officer | -2.37k | 0.00 | Derivative Exercise and Sale | - | 54.80k | - |
| 2025-12-29 | Dr. David S. TierneyIndependent Director | 1.33k | 0.00 | Derivative Exercise and Retained Stock | - | 383.31k | 0.35% |
| 2025-12-12 | Ms. Molly HarperLead Independent Director | -20.00k | 350.76k | Derivative Exercise and Sale | 5.78 - 23.73 | 2.36k | - |
| 2025-12-12 | Ms. Molly HarperLead Independent Director | -6.75k | 155.56k | 売り | 23.06 | 2.36k | -74.08% |
| 2025-12-08 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | 5.55k | 0.00 | Derivative Exercise and Retained Stock | - | 9.51k | 140.01% |
| 2025-12-08 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -2.49k | 0.00 | Derivative Exercise and Sale | - | 9.51k | - |
| 2025-12-08 | Mr. Donald A. DenkhausIndependent Director | 1.41k | 0.00 | Derivative Exercise and Retained Stock | - | 497.44k | 0.28% |
| 2025-12-08 | Ms. Molly HarperLead Independent Director | 1.41k | 0.00 | Derivative Exercise and Retained Stock | - | 9.11k | 18.37% |
| 2025-12-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | 4.29k | 0.00 | Derivative Exercise and Retained Stock | - | 238.46k | 1.83% |
| 2025-12-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | -2.78k | 0.00 | Derivative Exercise and Sale | - | 238.46k | - |
| 2025-12-08 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | 3.53k | 0.00 | Derivative Exercise and Retained Stock | - | 4.15M | 0.09% |
| 2025-12-08 | Dr. Preethi SundaramChief Strategy Officer | 5.19k | 0.00 | Derivative Exercise and Retained Stock | - | 50.51k | 11.44% |
| 2025-12-08 | Dr. Preethi SundaramChief Strategy Officer | -1.67k | 0.00 | Derivative Exercise and Sale | - | 50.51k | - |
| 2025-12-08 | Ms. Tamar ThompsonIndependent Director | 1.41k | 0.00 | Derivative Exercise and Retained Stock | - | 3.77k | 59.87% |
| 2025-12-08 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 11.87k | 0.00 | Derivative Exercise and Retained Stock | - | 1.08M | 1.11% |
| 2025-12-08 | Dr. David S. TierneyIndependent Director | 1.41k | 0.00 | Derivative Exercise and Retained Stock | - | 381.98k | 0.37% |
| 2025-12-01 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | -135.00k | 0.00 | Other Disposition | - | 4.15M | -3.15% |
| 2025-11-26 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -10.98k | 210.01k | Derivative Exercise and Sale | 4.21 - 23.33 | 3.96k | - |
| 2025-11-21 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | 4.41k | 0.00 | Derivative Exercise and Retained Stock | - | 8.61k | 105.05% |
| 2025-11-21 | Mr. Michael W. KalbExec. VP, Treasurer & CFO | -2.49k | 0.00 | Derivative Exercise and Sale | - | 8.61k | - |
| 2025-11-21 | Ms. Tamar ThompsonIndependent Director | 947.00 | 0.00 | Derivative Exercise and Retained Stock | - | 2.36k | 67.02% |
| 2025-11-21 | Dr. David S. TierneyIndependent Director | 947.00 | 0.00 | Derivative Exercise and Retained Stock | - | 380.57k | 0.25% |
| 2025-11-21 | Dr. Preethi SundaramChief Strategy Officer | 4.24k | 0.00 | Derivative Exercise and Retained Stock | - | 45.32k | 10.32% |
| 2025-11-21 | Dr. Preethi SundaramChief Strategy Officer | -1.36k | 0.00 | Derivative Exercise and Sale | - | 45.32k | - |
| 2025-11-21 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 8.27k | 0.00 | Derivative Exercise and Retained Stock | - | 1.07M | 0.78% |
| 2025-11-21 | Mr. Richard John DalyPresident, CEO & Director | 12.13k | 0.00 | Derivative Exercise and Retained Stock | - | 238.93k | 5.35% |
| 2025-11-21 | Mr. Richard John DalyPresident, CEO & Director | -7.87k | 0.00 | Derivative Exercise and Sale | - | 238.93k | - |
| 2025-11-21 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | 3.96k | 0.00 | Derivative Exercise and Retained Stock | - | 3.96k | - |
| 2025-11-21 | Mr. Jeffrey Del CarmenExec. VP & Chief Commercial Officer | -1.64k | 0.00 | Derivative Exercise and Sale | - | 3.96k | - |
| 2025-11-21 | Mr. Donald A. DenkhausIndependent Director | 947.00 | 0.00 | Derivative Exercise and Retained Stock | - | 496.03k | 0.19% |
| 2025-11-21 | Mr. Brian ElsberndCCO & Chief Legal Officer | 3.13k | 0.00 | Derivative Exercise and Retained Stock | - | 234.17k | 1.36% |
| 2025-11-21 | Mr. Brian ElsberndCCO & Chief Legal Officer | -2.03k | 0.00 | Derivative Exercise and Sale | - | 234.17k | - |
| 2025-11-21 | Ms. Molly HarperLead Independent Director | 947.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.69k | 14.04% |
| 2025-11-21 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | 1.78k | 0.00 | Derivative Exercise and Retained Stock | - | 4.28M | 0.04% |
| 2025-11-12 | Mr. Brian ElsberndCCO & Chief Legal Officer | -40.00k | 908.00k | 売り | 22.70 | 231.04k | -14.76% |
| 2025-09-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | 82.48k | 184.74k | Derivative Exercise and Retained Stock | 2.24 | 271.04k | 43.74% |
| 2025-09-08 | Mr. Brian ElsberndCCO & Chief Legal Officer | -30.00k | 541.80k | Derivative Exercise and Sale | 2.24 - 20.30 | 271.04k | - |
| 2025-09-03 | Mr. Brian ElsberndCCO & Chief Legal Officer | -50.00k | 875.20k | Derivative Exercise and Sale | 2.24 - 20.08 | 188.56k | - |
| 2025-08-27 | Dr. David S. TierneyIndependent Director | 24.00k | 53.76k | Derivative Exercise and Retained Stock | 2.24 | 379.62k | 6.75% |
| 2025-08-27 | Dr. David S. TierneyIndependent Director | -26.00k | 466.96k | Derivative Exercise and Sale | 2.24 - 20.20 | 379.62k | - |
| 2025-08-26 | Mr. Richard John DalyPresident, CEO & Director | 27.03k | 60.55k | Derivative Exercise and Retained Stock | 2.24 | 226.79k | 13.53% |
| 2025-08-26 | Mr. Richard John DalyPresident, CEO & Director | -22.97k | 422.19k | Derivative Exercise and Sale | 2.24 - 20.62 | 226.79k | - |
| 2025-08-27 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | 110.00k | 246.40k | Derivative Exercise and Retained Stock | 2.24 | 1.06M | 11.58% |
| 2025-08-26 | Dr. Steven R. MillerExec. VP, COO & Chief Scientific Officer | -115.00k | 2.07M | Derivative Exercise and Sale | 2.24 - 20.28 | 1.06M | - |
| 2025-06-10 | Dr. Preethi SundaramChief Strategy Officer | -3.92k | 103.65k | 売り | 26.41 - 26.42 | 41.08k | -8.72% |
| 2025-06-06 | Mr. Patrick J. McEnanyCo-Founder & Non-Executive Chairman | -200.00k | 5.22M | 売り | 25.95 - 26.11 | 4.28M | -4.46% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
